Yesterday afternoon the FDA announced that it would permit 23andMe to market its Personal Genome Service Pharmacogenetic Reports test. The test offers consumers information on whether they posses one ...

Amazon Prime Day isn't over just yet: The online retail giant is still dishing out deals on thousands of its best-selling products. Just when you thought you were all shopped out, Amazon rolls out ...

Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients. New ...

Regeneron Pharmaceuticals (REGN) was the top bidder at a bankruptcy auction and said Monday it will acquire substantially all of DNA-testing outfit 23andMe (MEHCQ) for $256 million. The biotech ...

April 22 (Reuters) - Bankrupt genetic test company 23andMe may face opposition from the U.S. government if it tries to sell itself to a foreign buyer, according to a Tuesday court filing by national ...

DNA testing company 23andMe (MEHCQ) is being purchased out of bankruptcy by large-cap drugmaker Regeneron (REGN) for $256 million. The deal includes "substantially all assets" but excludes the ...

Add Yahoo as a preferred source to see more of our stories on Google. Anne Wojcicki, the former chief executive of 23andMe, speaks at UC San Francisco's Genentech Hall in 2013. (Jeff Chiu / Associated ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. This year, skip the clutter and gift pure ...